rs4988321

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BA1

The NM_002335.4(LRP5):​c.1999G>A​(p.Val667Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0453 in 1,614,070 control chromosomes in the GnomAD database, including 1,942 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.035 ( 140 hom., cov: 32)
Exomes 𝑓: 0.046 ( 1802 hom. )

Consequence

LRP5
NM_002335.4 missense

Scores

2
8
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:14O:2

Conservation

PhyloP100: 7.87

Publications

89 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • LRP5-related exudative vitreoretinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • exudative vitreoretinopathy 4
    Inheritance: Unknown, AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the LRP5 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 71 curated pathogenic missense variants (we use a threshold of 10). The gene has 23 curated benign missense variants. Gene score misZ: 1.6684 (below the threshold of 3.09). Trascript score misZ: 3.6986 (above the threshold of 3.09). GenCC associations: The gene is linked to exudative vitreoretinopathy 4, autosomal dominant osteopetrosis 1, osteoporosis-pseudoglioma syndrome, autosomal dominant osteosclerosis, Worth type, polycystic liver disease 4 with or without kidney cysts, bone mineral density quantitative trait locus 1, osteosclerosis-developmental delay-craniosynostosis syndrome, hyperostosis corticalis generalisata, exudative vitreoretinopathy, polycystic liver disease 1, inherited retinal dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0044097304).
BP6
Variant 11-68406721-G-A is Benign according to our data. Variant chr11-68406721-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 6276.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0502 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002335.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP5
NM_002335.4
MANE Select
c.1999G>Ap.Val667Met
missense
Exon 9 of 23NP_002326.2O75197
LRP5
NM_001291902.2
c.256G>Ap.Val86Met
missense
Exon 9 of 23NP_001278831.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP5
ENST00000294304.12
TSL:1 MANE Select
c.1999G>Ap.Val667Met
missense
Exon 9 of 23ENSP00000294304.6O75197
LRP5
ENST00000529993.5
TSL:1
n.*605G>A
non_coding_transcript_exon
Exon 9 of 23ENSP00000436652.1E9PHY1
LRP5
ENST00000529993.5
TSL:1
n.*605G>A
3_prime_UTR
Exon 9 of 23ENSP00000436652.1E9PHY1

Frequencies

GnomAD3 genomes
AF:
0.0347
AC:
5287
AN:
152158
Hom.:
140
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00975
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0427
Gnomad ASJ
AF:
0.0876
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0253
Gnomad FIN
AF:
0.00990
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0517
Gnomad OTH
AF:
0.0540
GnomAD2 exomes
AF:
0.0381
AC:
9565
AN:
251330
AF XY:
0.0388
show subpopulations
Gnomad AFR exome
AF:
0.00800
Gnomad AMR exome
AF:
0.0325
Gnomad ASJ exome
AF:
0.0932
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0118
Gnomad NFE exome
AF:
0.0525
Gnomad OTH exome
AF:
0.0548
GnomAD4 exome
AF:
0.0464
AC:
67886
AN:
1461794
Hom.:
1802
Cov.:
33
AF XY:
0.0461
AC XY:
33492
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.00890
AC:
298
AN:
33478
American (AMR)
AF:
0.0348
AC:
1556
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0924
AC:
2414
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.0269
AC:
2322
AN:
86258
European-Finnish (FIN)
AF:
0.0130
AC:
694
AN:
53376
Middle Eastern (MID)
AF:
0.0954
AC:
550
AN:
5768
European-Non Finnish (NFE)
AF:
0.0515
AC:
57290
AN:
1111966
Other (OTH)
AF:
0.0457
AC:
2758
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
3691
7382
11073
14764
18455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2122
4244
6366
8488
10610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0347
AC:
5287
AN:
152276
Hom.:
140
Cov.:
32
AF XY:
0.0337
AC XY:
2507
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00972
AC:
404
AN:
41560
American (AMR)
AF:
0.0426
AC:
651
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0876
AC:
304
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5188
South Asian (SAS)
AF:
0.0257
AC:
124
AN:
4824
European-Finnish (FIN)
AF:
0.00990
AC:
105
AN:
10608
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
292
European-Non Finnish (NFE)
AF:
0.0517
AC:
3514
AN:
68016
Other (OTH)
AF:
0.0534
AC:
113
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
275
550
824
1099
1374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0495
Hom.:
944
Bravo
AF:
0.0375
TwinsUK
AF:
0.0515
AC:
191
ALSPAC
AF:
0.0477
AC:
184
ESP6500AA
AF:
0.0127
AC:
56
ESP6500EA
AF:
0.0559
AC:
480
ExAC
AF:
0.0375
AC:
4557
Asia WGS
AF:
0.0130
AC:
44
AN:
3478
EpiCase
AF:
0.0580
EpiControl
AF:
0.0569

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (6)
-
-
4
not specified (4)
1
-
1
Osteoporosis with pseudoglioma (3)
-
-
1
Disorder of bone (1)
-
-
1
Osteogenesis imperfecta (1)
-
-
1
Osteoporosis with pseudoglioma;C0432273:Worth disease;C1843330:Autosomal dominant osteopetrosis 1;C1851402:Exudative vitreoretinopathy 1;C1866176:Exudative vitreoretinopathy 4;C4693479:Polycystic liver disease 4 with or without kidney cysts (1)
-
-
1
Osteoporosis;C0432252:Osteoporosis with pseudoglioma;C0432273:Worth disease;C1843330:Autosomal dominant osteopetrosis 1;C1851402:Exudative vitreoretinopathy 1;C1866079:Bone mineral density quantitative trait locus 1;C1866176:Exudative vitreoretinopathy 4;C4693479:Polycystic liver disease 4 with or without kidney cysts (1)
-
1
-
Retinal dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Pathogenic
0.18
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T
Eigen
Uncertain
0.68
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0044
T
MetaSVM
Uncertain
0.0064
D
MutationAssessor
Uncertain
2.4
M
PhyloP100
7.9
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.55
Sift
Benign
0.039
D
Sift4G
Benign
0.093
T
Polyphen
0.99
D
Vest4
0.17
MPC
0.43
ClinPred
0.049
T
GERP RS
4.1
Varity_R
0.13
gMVP
0.71
Mutation Taster
=32/68
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4988321; hg19: chr11-68174189; COSMIC: COSV53713597; COSMIC: COSV53713597; API